Silicon Laboratories Inc. — Form 10-Q Summary
Reporting-period note: Although the request identifies 2010 Q2, this filing reports the unaudited quarter ended July 2, 2011 (fiscal 2011 Q2), with comparisons to the quarter ended July 3, 2010. The six-month period also ended July 2, 2011.
Business context
Silicon Laboratories designs analog-intensive, mixed-signal integrated circuits and operates as a fabless semiconductor company, relying on third parties for wafer fabrication, assembly and testing. Its products serve communications, consumer, industrial, automotive, medical and power-management markets. The filing says Samsung represented more than 10% of first-half revenue; three distributors represented 23%, 13% and 11%, respectively. Customers outside the United States generated 85% of first-half revenue.
Financial performance
| Metric | Q2 2011 | Q2 2010 | Six months 2011 | Six months 2010 |
|---|---|---|---|---|
| Revenue | $126.2 million | $134.6 million | $245.8 million | $261.3 million |
| Gross margin | $76.2 million; 60.4% | $90.9 million; 67.5% | $148.4 million; 60.4% | $174.5 million; 66.8% |
| Operating income | $16.0 million | $30.6 million | $20.9 million | $56.3 million |
| Net income | $13.4 million | $21.0 million | $11.4 million | $42.1 million |
| Diluted EPS | $0.29 | $0.44 | $0.25 | $0.88 |
| Operating cash flow | Not separately reported for the quarter | $26.2 million | $52.5 million |
Q2 revenue fell 6.2% year over year; first-half revenue declined 5.9%. Management attributed the decline primarily to weaker demand for consumer-oriented products. Unit volumes fell 11.2% in Q2 and 12.2% in the first half, partly offset by average selling-price increases of 6.1% and 7.7%, respectively. Gross-margin pressure reflected product mix, lower sales, Spectra Linear acquisition-related charges and a one-time in-process-material cancellation charge.
First-half R&D expense rose 15.1% to $69.5 million; SG&A was $57.9 million, broadly level year over year. First-half effective tax rate rose to 48.9% from 25.7%, principally due to taxes on an intercompany technology license and nondeductible Spectra Linear acquisition costs. Q2’s rate was 19.5%, versus 31.4% a year earlier. First-half net income was below Q2 net income; the filing attributes the first-half tax burden in part to first-quarter acquisition-related items.
Balance sheet, liquidity and capital allocation
- At July 2, 2011, cash and cash equivalents were $134.8 million, short-term investments $198.8 million, and long-term investments $17.2 million. Management described cash, cash equivalents and short-term investments of $333.6 million as principal liquidity.
- Current assets were $486.8 million and current liabilities $86.1 million. Total assets were $744.3 million; total liabilities were $107.7 million; stockholders’ equity was $636.6 million.
- The balance sheet reports $21.5 million of long-term obligations and other liabilities; the filing does not provide a clear total debt figure. The company paid $7.2 million on debt assumed in the Spectra Linear acquisition during the first half.
- Operating cash flow of $26.2 million was down from $52.5 million. Investing used $4.0 million, including $27.3 million for acquisitions, partly offset by investment maturities and sales. Financing used $26.0 million, including $23.2 million of share repurchases.
- Accounts receivable increased to $70.4 million from $45.0 million at fiscal year-end; DSO rose to 50 days from 36. Inventory declined to $38.1 million; DOI improved to 69 days from 87.
- The company repurchased 0.6 million shares for approximately $24.0 million in the first half. Its buyback authorization allowed up to $150 million through 2011.
Outlook, management commentary and key risks
For fiscal 2011 Q3, management forecast revenue of $113.5 million to $120 million and diluted EPS of $0.16 to $0.22. It expected R&D and SG&A expense to increase in absolute dollars in Q3, and anticipated fiscal 2011 capital expenditures of approximately $15 million to $20 million. Management said existing cash and investment balances should meet capital requirements for at least 12 months.
In January 2011, the company acquired Spectra Linear for approximately $28.6 million, including contingent consideration; it also assumed about $8.0 million of net liabilities. The purchase-price allocation was preliminary. Acquisition-related charges affected reported costs and taxes. Management cited consumer-product demand weakness and noted that semiconductor demand, product mix, pricing, customer orders and seasonality can cause substantial period-to-period volatility.
Liquidity and valuation risks include $19.4 million par value of auction-rate securities with failed auctions, carried at $17.2 million and with contractual maturities from 2029 to 2046. The company receives underlying cash flows but cannot predict when principal will become accessible. A remaining interest-rate swap was a $2.9 million liability; its agreement requires at least $150 million of unencumbered cash and highly rated short-term investments or collateral may be required. The filing says no collateral had been posted.
Other disclosed exposures include customer and distributor concentration, reliance on third-party manufacturing and testing, inventory and receivables risks, acquisition integration and contingent consideration, foreign operations, and intellectual-property and product-liability claims. An IPO-related securities class action settlement was approved but remained subject to an appeal process; the company stated that an adverse outcome if the settlement did not survive appeal could have a material effect, though insurers were to fund the settlement. The company also disclosed contingent lease exposure tied to headquarters sale proceeds and an uncapped contractual indemnification for certain tax matters related to a 2007 product-line sale; no material liability was recorded for the latter.
Most important facts for investors to verify
- Confirm the filing period: this is fiscal 2011 Q2, not 2010 Q2, and compare the Q3 forecast with subsequent reported results.
- Assess whether weaker consumer-oriented demand, lower unit volumes and reduced gross margin persisted or improved.
- Review cash conversion and working-capital trends, particularly the increase in receivables and DSO, alongside inventory and DOI.
- Evaluate the effect of Spectra Linear integration, acquisition-related costs, contingent payments and preliminary purchase accounting.
- Verify liquidity availability and valuation developments for failed-auction securities, as well as any swap collateral requirements.
- Check the status and potential financial effects of the securities litigation appeal, lease contingencies and tax exposures.